Chongqing Lummy Pharmaceutical Co.,Ltd. Posted 76.3 Million Yuan Net Loss in 2022

Chongqing Lummy Pharmaceutical Co.,Ltd. (重庆莱美药业股份有限公司) (300006.SZ) reported a net loss of 76.3 million yuan in 2022, narrowing 28% year-on-year.

Meanwhile, the company posted 884.6 million yuan in revenue, down 27.8% year-on-year.

At the end of the reporting period, it had 3.1 billion yuan in total assets and 870 million yuan in total liabilities, with a liability-to-asset ratio of 28.5%.